EC Clinical and Medical Case Reports

Background and Objective: Establish a strategy for cardiovascular risk management in patients with Arterial Hypertension over 40 years of age in two hospitals in Tegucigalpa - Honduras, January - June 2022, for monitoring and scheduled intervention through teleconsultation.

Methodology: The study, carried out at the University School Hospital and the Honduran Institute of Social Security in Honduras, was descriptive, observational and longitudinal, focused on patients over 40 years of age. It involved clinical and laboratory tests, as well as teleconsultation follow-up, to evaluate cardiovascular risk and other parameters in 1,000 patients. Primary outcomes included deaths, cardiovascular events, and hospital readmissions. The limitations were budgetary, internet access and laboratory standardization. The data was analyzed with Epi Info and TGF Medical Software, and the findings were shared via Zoom on February 7, 2022.

Results: The study showed that the majority of patients over 40 years of age were women (67.4%), with an average age of 60 years. High blood pressure and type 2 diabetes mellitus were common, affecting 72.6% and 66.7% respectively. Almost half of the hypertensive patients (49.2%) had a moderate cardiovascular risk. Furthermore, 33.9% of hypertensive patients had high cholesterol, and 35.4% were classified as overweight. Regarding satisfaction with teleconsultation, 39.2% of respondents expressed satisfaction, with 34.1% very satisfied.

Conclusion: In the study, 49.2% of participants showed a moderate cardiovascular risk and 30.8% of hypertensive patients were dissatisfied with virtual medical care. Evaluating satisfaction was difficult for 60% of the cases due to telephone changes or deaths.

 Keywords: Cardiovascular Risk Management; Arterial Hypertension; Honduras; Internal Medicine

1. Wilson P. “Atherosclerotic cardiovascular disease risk assessment for primary prevention in adults: Our approach”. UptoDate. [On-line] (2020).
2. Ordoñez Salgado F., et al. “Cardiovascular risk”. Medicine-Continuing Medical Training Program42 (2017).
3. World Health Organization. “Global Action Plan for the Prevention and Control of Noncommunicable Diseases”. [On-line]. 2013-2020 (2021).
4. D'Agostino RB Sr., et al. “Validation of the Framingham coronary heart disease prediction scores: results from a multi-ethnic investigation”. JAMA2 (2001): 180-187.
5. Goff DC Jr., et al. “2013 ACC/AHA Guidelines for Cardiovascular Risk Assessment: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines”. Circulation 129 (2014): S49-S73.
6. Arnett DK., et al. “2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines”. Circulation 11 (2019): e596-e646.
7. Hajifathalian K., et al. “A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys”. Lancet Diabetes and Endocrinology5 (2015): 339-355.
8. Pan American Health Organization. Consulted January 10, 2022.
9. Castellini Y., et al. “Prevalence of Hypertension and associated factors in the adult community of Billinghurst, General San Martín district”. [Nursing research workshop on the Internet]. [Argentina]. National University of San Martín (2020).
10. Sánchez B and Gómez N. “Association of arterial hypertension with sex in a medical office population”. University and Society S3 (2021): 387-391.
11. Romero Giraldo M., et al. “Differences by sex in the factors associated with high blood pressure in Peru: analysis of the 2017 Demographic and Family Health Survey”. Anales de la Facultad de Medicina 1 (2020): 33-39.
12. García Casilimas GA., et al. “Pathophysiology of arterial hypertension secondary to obesity”. Archives of Cardiology of Mexico4 (2017): 336-344.
13. AlMarri EA and Al-Hamad J. “Prevalence of obesity among hypertensive patients in Primary Care Clinic, Security Forces Hospital, Riyadh, Saudi Arabia 2017-2018: A prospective cross-sectional study”. Journal of Family Medicine and Primary Care4 (2020): 1885-1890.
14. Osorio-Bedoya EJ and Amariles P. “Arterial hypertension in elderly patients: a structured review”. Revista Colombiana de Cardiología 3 (2018): 209-221.
15. Romero Giraldo M., et al. “Differences by sex in the factors associated with high blood pressure in Peru: analysis of the 2017 Demographic and Family Health Survey”. Anales de la Facultad de Medicina 1 (2020): 33-39.
16. Román O., et al. “Morbi - Mortality from Arterial Hypertension according to the magnitude of the change in risk factors. 30-year follow-up”. Revista Chilena de Cardiología 1 (2005).
17. García U. “Dyslipidemias and arterial hypertension”. Gaceta Médica de México 1 (2016): 56-62.
18. Córdova M. “Prevalence of Dyslipidemia in Adults 40 - 64 Years Old, Cuenca - Ecuador, January to July 2014”. HJCA Medical Journal3 (2018).
19. León G. “Prevalence of obesity and dyslipidemia, and its relationship with arterial hypertension in university workers in Ecuador”. Collective Health and Wellbeing Magazine1 (2020): 33-43.